South San Francisco, CA, United States of America

Marcos Gonzalez-Lopez

USPTO Granted Patents = 6 


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marcos Gonzalez-Lopez

Introduction

Marcos Gonzalez-Lopez is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 6 patents to his name, his work continues to impact the medical community.

Latest Patents

Among his latest patents are innovative compounds known as AhR modulators. These compounds, compositions, and methods are designed for the treatment of diseases modulated, at least in part, by AhR. The compounds are represented by specific formulae, wherein the letters and symbols X, Z, R, and others have defined meanings provided in the specification. Another notable patent involves dihydrothieno[3,2-b]pyridine compounds, which are characterized by Formula (I). These compounds have utility in treating diseases, either alone or in combination with other agents.

Career Highlights

Marcos is currently associated with Ideaya Biosciences, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is instrumental in developing new therapeutic options that can significantly improve patient outcomes.

Collaborations

Throughout his career, Marcos has collaborated with talented individuals such as Hilary Plake Beck and James Clifford Sutton, Jr. These collaborations have fostered an environment of innovation and creativity, leading to groundbreaking advancements in their field.

Conclusion

Marcos Gonzalez-Lopez exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…